Platelet function beyond hemostasis and thrombosis

Current Opinion in Hematology

Volumn 20, Issue 5, 2013, Pages 451-456

  Ware, Jerry ^a   Corken, Adam ^a   Khetpal, Reshma ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

cancer; infection; inflammation; neural disease

Indexed keywords

ACETYLSALICYLIC ACID; DROTRECOGIN; ERITORAN; INTERLEUKIN 1; INTERLEUKIN 1BETA; PATTERN RECOGNITION RECEPTOR; THROMBOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; BACTERIAL ENDOCARDITIS; BLOOD CLOTTING; BRAIN MALARIA; CARCINOGENESIS; DEPRESSION; DISSEMINATED INTRAVASCULAR CLOTTING; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE RELEASE REACTION; THROMBOCYTOSIS; THROMBOSIS; TRANSFUSION RELATED ACUTE LUNG INJURY; WOUND HEALING;

BLOOD PLATELETS; COMMUNICABLE DISEASES; HEMOSTASIS; HUMANS; INFLAMMATION; NEOPLASMS;

EID: 84883275850     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32836344d3     Document Type: Review

References (64)

1. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010; 328:562-564.
2. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11:264-274.
3. Levin J. The evolution of mammalian platelets. In: Michelson AD, editor. Platelets, 3rd ed. New York: Elsevier Inc; 2013. pp. 3-25.
4. St Paul M, Paolucci S, Barjesteh N, et al. Characterization of chicken thrombocyte responses to Toll-like receptor ligands. PLoS One 2012; 7:e43381.
5. Huang HS, Chang HH. Platelets in inflammation and immune modulations: functions beyond hemostasis. Arch Immunol Ther Exp (Warsz) 2012; 60: 443-451.
6. Ghasemzadeh M, Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb Res 2013; 131:191-197.
7. Andonegui G, Kerfoot SM, McNagny K, et al. Platelets express functional Toll-like receptor-4. Blood 2005; 106:2417-2423.
8. Cognasse F, Hamzeh H, Chavarin P, et al. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 2005; 83:196-198.
9. Cognasse F, Hamzeh-Cognasse H, Lafarge S, et al. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 2008; 141:84-91.
10. Berthet J, Damien P, Hamzeh-Cognasse H, et al. Toll-like receptor 4 signal transduction in platelets: novel pathways. Br J Haematol 2010; 151:89-92.
11. Zhang G, Han J, Welch EJ, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009; 182:7997-8004.
12. Zago AC, Simon DI, Wang Y, et al. The importance of the interaction between leukocyte integrin Mac-1 and platelet glycoprotein Iba for leukocyte recruitment by platelets and for the inflammatory response to vascular injury. Arq Bras Cardiol 2008; 90:54-63.
13. Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17:1381-1390.
14. Projahn D, Koenen RR. Platelets: key players in vascular inflammation. J Leukoc Biol 2012; 92:1167-1175.
15. Seizer P, Gawaz M, May AE. Platelet-monocyte interactions: a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 2008; 15:1976-1980.
16. Boilard E, Blanco P, Nigrovic PA. Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol 2012; 8:534-542.
17. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327:580-583.
18. Zimmerman GA, Weyrich AS. Immunology. Arsonists in rheumatoid arthritis. Science 2010; 327:528-529.
19. Mueller K. Inflammation's yin-yang. Introduction. Science 2013; 339: 155.
20. O'Brien M. The reciprocal relationship between inflammation and coagulation. Top Companion Anim Med 2012; 27:46-52.
21. Langer HF, Choi EY, Zhou H, et al. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 2012; 110:1202-1210.
22. Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol 2010; 30:2357-2361.
23. Fuentes QE, Fuentes QF, Andres V, et al. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 2012; 24:255-262.
24. Li N. CD4+ T cells in atherosclerosis: regulation by platelets. Thromb Haemost 2013; 109. [Epub ahead of print]
25. Caudrillier A, Looney MR. Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injury. Curr Pharm Des 2012; 18:3260-3266.
26. Levinson AT, Casserly BP, Levy MM. Reducing mortality in severe sepsis and septic shock. Semin Respir Crit Care Med 2011; 32:195-205.
27. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, et al. The pathogenesis of sepsis. Annu Rev Pathol 2011; 6:19-48.
28. Williams SC. After Xigris, researchers look to new targets to combat sepsis. Nat Med 2012; 18:1001.
29. Grewal PK, Uchiyama S, Ditto D, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008; 14:648-655.
30. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110:3507-3512.
31. Goubran HA, Burnouf T, Radosevic M, El-Ekiaby M. The platelet-cancer loop. Eur J Intern Med 2013. [Epub ahead of print].
32. Dammacco F, Vacca A, Procaccio P, et al. Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med 2013; 13:85-97.
33. Yapijakis C, Bramos A, Nixon AM, et al. The interplay between hemostasis and malignancy: the oral cancer paradigm. Anticancer Res 2012; 32:1791-1800.
34. Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2012; 2:1091-1099.
35. Kerr BA, McCabe NP, Feng W, Byzova TV. Platelets govern premetastatic tumor communication to bone. Oncogene 2012. [Epub ahead of print]
36. Rothwell PM, Price JF, Fowkes FG, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and nonvascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379:1602-1612.
37. Rothwell PM, Wilson M, Price JF, et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012; 379:1591-1601.
38. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012; 13:518-527.
39. Kaiser J. Wondering how the wonder drug works. Science 2012; 337:1472.
40. De Berardis G, Lucisano G, D'Ettorre A, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012; 307:2286-2294.
41. Kaiser J. Will an aspirin a day keep cancer away? Science 2012; 337:1471-1473.
42. Bruno A, Dovizio M, Tacconelli S, Patrignani P. Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2012; 26:e1-e13.
43. Casado-Arroyo R, Gargallo C, Lanas AA. Balancing the risk and benefits of low-dose aspirin in clinical practice. Best Pract Res Clin Gastroenterol 2012; 26:173-184.
44. Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis? Lancet 1998; 352:1775-1777.
45. Patzelt J, Langer HF. Platelets in angiogenesis. Curr Vasc Pharmacol 2012; 10:570-577.
46. Peterson JE, Zurakowski D, Italiano JE Jr, et al. Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol 2010; 85:487-493.
47. Italiano JE Jr, Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008; 111:1227-1233.
48. Battinelli EM, Markens BA, Italiano JE Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011; 118:1359-1369.
49. Kamykowski J, Carlton P, Sehgal S, Storrie B. Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet a-granules. Blood 2011; 118:1370-1373.
50. Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer 2012; 130:2747-2760.
51. Lian L, Li W, Li ZY, et al. Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Oncol Lett 2013; 5:675-680.
52. Serebruany V, Floyd J, Chew D. Excess of solid cancers after prasugrel: the Food and Drug Administration outlook. Am J Ther 2010. [Epub ahead of print]
53. Cattaneo M. Prasugrel and cancer. Arch Intern Med 2010; 170: 1944.
54. Zhang W, Dang S, Hong T, et al. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood 2012; 120:2889-2898.
55. Ware J. Fragmenting the platelet to reduce metastasis. Blood 2012; 120:2779-2780.
56. Wistuba II, Gelovani JG, Jacoby JJ, et al. Methodological and practical challenges for personalized cancer therapies. Nat Rev 2013; 8:135-141.
57. Aggrey AA, Srivastava K, Ture S, et al. Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria. J Immunol 2013. [Epub ahead of print]
58. McMorran BJ, Wieczorski L, Drysdale KE, et al. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 2012; 338:1348-1351.
59. Engwerda CR, Good MF. Immunology. Platelets kill the parasite within. Science 2012; 338:1304-1305.
60. Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci 2010; 67:513-523.
61. Tilley DO, Arman MA, Smolenski A, et al. Glycoprotein Iba and FcgRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost 2013. [Epub ahead of print]
62. Plummer C, Wu H, Kerrigan SW, et al. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol 2005; 129:101-109.
63. Reed GL, Fitzgerald ML, Polgá r J. Molecular mechanisms of platelet exocytosis: insights into the 'secrete' life of thrombocytes. Blood 2000; 96:3334-3342.
64. Ziu E, Mercado CP, Li Y, et al. Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. J Mol Cell Cardiol 2012; 52:1112-1121.